Title
Optimal Implantable Cardioverter-defibrillator Programming and Testing
Authoring Organization
Publication Month/Year
May 15, 2019
Last Updated Month/Year
January 30, 2024
Supplemental Implementation Tools
Document Type
Consensus
External Publication Status
Published
Country of Publication
US
Document Objectives
Guidance on bradycardia programming, tachycardia detection, tachycardia therapy, and defibrillation testing for implantable cardioverter-defibrillator (ICD) patient treatment
Inclusion Criteria
Female, Male, Adult, Older adult
Health Care Settings
Ambulatory, Hospital
Intended Users
Nurse, nurse practitioner, physician, physician assistant
Scope
Management
Diseases/Conditions (MeSH)
D016757 - Death, Sudden, Cardiac, D006333 - Heart Failure, D054143 - Heart Failure, Systolic, D017180 - Tachycardia, Ventricular
Keywords
implantable cardioverter-defibrillator, sudden cardiac death, ventricular fibrillation, ventricular tachycardia, cardiovascular implantable electronic device (CIED)
Source Citation
Stiles MK, Fauchier L, Morillo CA, Wilkoff BL. 2019 HRS/EHRA/APHRS/LAHRS focused update to 2015 expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing. Hear Rhythm [Internet]. 2020;17(1):e220–8. Available from: https://doi.org/10.1016/j.hrthm.2019.02.034